首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   135175篇
  免费   12903篇
  国内免费   8501篇
耳鼻咽喉   1089篇
儿科学   1868篇
妇产科学   1006篇
基础医学   11002篇
口腔科学   2566篇
临床医学   16658篇
内科学   14835篇
皮肤病学   1371篇
神经病学   4956篇
特种医学   4630篇
外国民族医学   39篇
外科学   13125篇
综合类   32079篇
现状与发展   26篇
一般理论   16篇
预防医学   13561篇
眼科学   2179篇
药学   16107篇
  146篇
中国医学   11017篇
肿瘤学   8303篇
  2024年   527篇
  2023年   1829篇
  2022年   4593篇
  2021年   5679篇
  2020年   4904篇
  2019年   3178篇
  2018年   3469篇
  2017年   3906篇
  2016年   3270篇
  2015年   5645篇
  2014年   7380篇
  2013年   8102篇
  2012年   11924篇
  2011年   12908篇
  2010年   10449篇
  2009年   9054篇
  2008年   9399篇
  2007年   9187篇
  2006年   8510篇
  2005年   7284篇
  2004年   5058篇
  2003年   4308篇
  2002年   3506篇
  2001年   2968篇
  2000年   2474篇
  1999年   1505篇
  1998年   853篇
  1997年   833篇
  1996年   670篇
  1995年   582篇
  1994年   450篇
  1993年   334篇
  1992年   274篇
  1991年   221篇
  1990年   211篇
  1989年   198篇
  1988年   154篇
  1987年   142篇
  1986年   119篇
  1985年   116篇
  1984年   58篇
  1983年   36篇
  1982年   39篇
  1981年   25篇
  1980年   19篇
  1979年   20篇
  1965年   16篇
  1958年   29篇
  1957年   20篇
  1956年   14篇
排序方式: 共有10000条查询结果,搜索用时 140 毫秒
31.
32.
33.
34.
35.
36.
37.
目的观察关节镜下采用自体腘绳肌腱经胫骨隧道前交叉韧带(anterior cruciate ligament, ACL)双束八股解剖重建的临床效果。方法随访上海交通大学附属第六人民医院运动医学科2018年12月—2020年1月收治的103例ACL断裂患者资料,其中男78例,女25例,年龄18~45岁,平均(26.8±5.86)岁;左侧47例,右侧56例,均采用关节镜下自体腘绳肌腱经胫骨隧道打股骨骨隧道,ACL双束八股解剖重建。按照Lysholm评分、国际膝关节评分委员会(IKDC)膝关节评分、Tegner膝关节评分标准和膝关节自我效能量表K-SES评价疗效。结果所有患者术后获随访12~42个月,平均(24±8.18)个月;手术前、末次随访评分比较,Lysholm评分分别为(48.41±4.44)分和(95.34±1.91)分,2组比较差异有统计学意义(P<0.001);IKDC评分分别为(44.05±4.36)分和(95.66±1.89)分,2组比较差异有统计学意义(P<0.001);Tegner评分分别为(2.84±0.95)分和(6.15±0.89)分,2组比较差异有统计学意义(P<0.001);膝关节自我效能量表K-SES量表(3.10±0.83)分和(7.12±1.10)分,2组比较差异有统计学意义(P<0.001)。末次随访103例患者前抽屉试验阴性,轴移试验阴性。98例(95.1%)Lachman试验阴性,5例(4.9%)Lachman试验1°阳性。结论关节镜下采用自体腘绳肌腱经胫骨隧道双束八股解剖重建前交叉韧带是一种恢复膝关节稳定性,恢复伤前活动水平的有效方法。  相似文献   
38.
39.
Discoid lupus erythematosus (DLE) is the most common skin manifestation of lupus; however, the molecular mechanisms underlying DLE remain unknown. Therefore, we aimed to identify key differentially expressed genes (DEGs) in discoid lupus skin and investigate their potential pathways.To identify candidate genes involved in the occurrence and development of the disease, we downloaded the microarray datasets GSE52471 and GSE72535 from the Gene Expression Database (GEO). DEGs between discoid lupus skin and normal controls were selected using the GEO2R tool and Venn diagram software (http://bioinformatics.psb.ugent.be/webtools/Venn/). The Database for Annotation, Visualization, and Integrated Discovery (DAVID), Enrichr, and Cytoscape ClueGo were used to analyze the Kyoto Encyclopedia of Gene and Genome pathways and gene ontology. Protein-protein interactions (PPIs) of these DEGs were further assessed using the Search Tool for the Retrieval Interacting Genes version 10.0.Seventy three DEGs were co-expressed in both datasets. DEGs were predominantly upregulated in receptor signaling pathways of the immune response. In the PPI network, 69 upregulated genes were selected. Furthermore, 4 genes (CXCL10, ISG15, IFIH1, and IRF7) were found to be significantly upregulated in the RIG-I-like receptor signaling pathway, from analysis of Enrichr and Cytoscape ClueGo.The results of this study may provide new insights into the potential molecular mechanisms of DLE. However, further experimentation is required to confirm these findings.  相似文献   
40.

Aim

Leukocyte-associated immunoglobulin-like receptor-1 (LAIR-1) is an immune inhibitory receptor which is expressed within most types of hematopoietic cells and negatively regulates immune responses. Recently, we found LAIR-1 expression to be present within tumors of nonhematopoietic lineages. However, the roles of LAIR-1 in hepatocellular carcinoma (HCC) have yet to be examined. The purpose of this study was to investigate the expression of LAIR-1 in HCC tissue and assess its clinical significance at this site.

Materials and methods

Expression levels of LAIR-1 within HCC samples collected from 90 patients and compared with that of slides of normal liver tissue collected from 9 non-HCC patients were measured by immunohistochemistry using tissue microarrays. A semiquantitative score was assigned, as was based on staining intensity and percent of positive cells and a Spearman Rank correlation test was used to assess any potential significant correlations between LAIR-1 expression and clinicopathological factors. Overall survival analysis was performed using the Kaplan-Meier and Log Rank statistical test.

Results

LAIR-1 expression was detected in cancer tissue and adjacent tumor tissue, but not in normal liver tissue. The percent of LAIR-1-positive expression in cancer tissue of HCC samples was 97.78% (88/90) while that in adjacent tumor tissue was 96.67% (87/90). Significantly greater expression levels of LAIR-1 were obtained from cancer tissue (Mean?±?SD?=?5.722?±?2.145) than that in adjacent tumor tissue (4.141?±?1.486). In addition, LAIR-1 expression was found to be significantly correlated with pathological grade of HCC, T stage, and age. Expression levels of LAIR-1 were related with worse overall survival rates of HCC patients, especially in HCC patients with hepatic cirrhosis.

Conclusion

Results of this study show that LAIR-1 is expressed in HCC tissues and that high levels of LAIR-1 expression are associated with the poor cancer differentiation. In addition, overexpression of LAIR-1 was significantly associated with worse overall survival in the patients with HCC. These data suggest that LAIR-1 may be an independent predictor for clinical outcomes in patients with HCC.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号